New Ballard Score — Gestational Age Assessment
Neuromuscular and physical maturity scoring system to estimate gestational age in neonates when dates are uncertain. Consists of 6 neuromuscular + 6 physical maturity criteria. Total score correlates to gestational age in weeks.
Score interpretation
Ballard score -10 to 14 — estimated gestational age <30 weeks (extremely/very preterm)
→ Level 3 NICU; surfactant therapy; respiratory support; thermoregulation; parenteral nutrition; indomethacin/ibuprofen for PDA; infection prevention; neuroprotective measures (magnesium, avoid hypoxia); family-centred care; neurodevelopmental follow-up
Ballard score 15–29 — estimated gestational age 30–36 weeks (preterm)
→ NICU/SCN care; respiratory monitoring; thermoregulation incubator; establish feeds (NG if unable to suck); caffeine for apnoea of prematurity; vitamin D and iron supplementation; jaundice monitoring; breastfeeding support; ophthalmology for ROP screening if <32 weeks
Ballard score ≥30 — estimated gestational age ≥37 weeks (term or post-term)
→ Routine newborn care; ensure adequate feeding; bilirubin monitoring; newborn examination; vitamin K prophylaxis; hearing screen; metabolic screen; promote skin-to-skin; arrange GP/midwife follow-up within 5 days of discharge
Interpretation bands for the Ballard Score. Apply clinical judgement and local guidance.
References
- Ballard JL et al. New Ballard Score, expanded to include extremely premature infants. J Pediatr. 1991;119(3):417–423.
Related
Curated clinical cross-links plus same-class fallbacks.
- Cisatracurium · Neuromuscular Blocking Agent (Non-Depolarising)
- Atracurium · Non-Depolarising Neuromuscular Blocking Agent
- Sugammadex · Selective Neuromuscular Blockade Reversal Agent
- Suxamethonium (Anaesthesia/RSI) · Depolarising Neuromuscular Blocking Agent
- Rocuronium (Anaesthesia/RSI) · Non-Depolarising Neuromuscular Blocking Agent
- Vecuronium · Non-Depolarising Neuromuscular Blocking Agent
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.